Dracula Technologies Secures €30M in Series A Round Valence, France-based Dracula Technologies has announced the successful completion of its Series A extension round, bringing the total S…
Neumora Therapeutics Announces Initiation of Phase 1 Clinical Study Neumora Therapeutics, Inc. has initiated a Phase 1 single-ascending do…
New Toronto Transit Station to Open A new station serving GO Transit's Kitchener Line and UP Express is set to open in weeks. Metro…
Horoscopes for October 27, 2025 Notable celebrities born on this day include Kelly Osbourne, Patrick Fugit, Peter Firth, and John Cleese.
Public Urged to Buy Fireworks from Reputable Traders Only Staffordshire County Council’s Trading Standards service is advising people to b…
Kymera Therapeutics Presents New Preclinical Data for KT-579 Kymera Therapeutics, Inc. announced the presentation of new preclinical data …
Rates of Physician Attrition From Clinical Practice Have Risen Since 2013 A recent study found that the rate of physician attrition from c…
Fi Europe 2025: A Key Return to Paris Registration is now open for Fi Europe 2025, celebrating its 30th edition in Paris from 2-4 December…
In the Age of Ozempic: Accessibility and Cost The effectiveness and cost of weight loss drugs like Ozempic, Wegovy, and Mounjaro have been…
OPPO and Ballet Philippines Partnership OPPO has announced a partnership with Ballet Philippines to promote Filipino artistry, marking the…
Biologicals: Too Good to Be True? Biologicals are being promoted as a natural replacement for 'chemicals', appearing under various names s…